Tirzepatide

Arctic Labs

Dual-Action Peptide

Two Receptors. One Molecule. Dual Activation Power

Tirzepatide represents a new class of peptides in metabolic research. Unlike traditional compounds that target a single pathway, tirzepatide is designed to activate two key receptors simultaneously: GLP-1 and GIP. This dual-receptor mechanism has been widely documented in peer-reviewed scientific literature for its role in studying glucose handling, energy balance, and appetite regulation.

• Activates GLP-1 and GIP receptors simultaneously

• First compound engineered with a true dual-receptor mechanism

• Long-acting profile suitable for once-weekly research protocols

• Extensively documented in peer-reviewed scientific journals

• Stable compound appropriate for controlled laboratory studies

For laboratory research use only. Not for human consumption.

Tirzepatide Research Compound

Intelligent Molecular Design

Why Dual Receptor Activation Matters

Tirzepatide was not designed to activate both receptors equally — and this is by design. The molecule binds strongly to GIP receptors, closely mimicking the body’s natural GIP hormone, while interacting more gently with GLP-1 receptors.

This intentionally “unbalanced” binding profile has been shown in research to produce a synergistic effect, where combined receptor activation leads to outcomes that exceed those seen with single-receptor compounds.

• Strong affinity for GIP receptors (comparable to endogenous GIP)

• Reduced affinity for GLP-1 receptors (~5× lower than native GLP-1)

• Synergistic interaction between both metabolic pathways

• Combined effects exceed single-receptor activation

• Expands possibilities for advanced metabolic research

For laboratory research use only. Not for human consumption.

Tirzepatide Dual Mechanism

Research Applications

What Researchers Study Using Tirzepatide

Due to its dual-pathway activity, tirzepatide has become a valuable research tool for investigating complex metabolic interactions. By activating both GLP-1 and GIP pathways simultaneously, researchers can explore questions that are difficult to isolate using single-receptor compounds.

Current research areas include:

• Glucose regulation and insulin signaling pathways

• Energy storage and energy utilization mechanisms

• Appetite signaling and satiety responses

• Hepatic (liver) lipid metabolism

• Cardiovascular and metabolic biomarkers

• Comparative studies between single- and dual-receptor activation

For laboratory research use only. Not for human consumption.

Tirzepatide – Metabolic Research Overview

Understanding the Science

Most peptides in metabolic research are designed to target a single receptor, such as GLP-1 agonists. Tirzepatide introduces a different approach by activating both GLP-1 and GIP receptors simultaneously, making it the first compound specifically engineered for this purpose.

What makes tirzepatide unique is its selective receptor interaction. The compound binds to GIP receptors with full biological strength, similar to the natural hormone, while engaging GLP-1 receptors more moderately — approximately five times weaker than endogenous GLP-1. Research indicates that this asymmetric interaction enhances overall pathway synergy rather than limiting effectiveness.

When these two pathways are activated together in this precise balance, researchers observe a synergistic response — where the combined activity exceeds what either pathway could achieve independently. This makes tirzepatide a powerful tool for studying interconnected metabolic systems.

With a long-acting molecular profile, tirzepatide is commonly utilized in once-weekly research protocols, allowing scientists to examine sustained receptor activation over time.

For laboratory research use only. Not for human consumption.